Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

65.58
Delayed Data
As of Oct 19
 +0.02 / +0.03%
Today’s Change
46.86
Today|||52-Week Range
66.11
+22.51%
Year-to-Date

Today’s Trading

Previous close65.56
Today’s open65.50
Day’s range65.16 - 65.69
Volume1,572,105
Average volume (3 months)2,169,816
Market cap$32.1B
Dividend yield0.64%
Data as of 4:01pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)+142.65%
Earnings growth (this year)+19.18%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+2.58%
P/E ratio37.1
Price/Sales5.46
Price/Book21.73

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+0.22+0.16%
INCYIncyte Corp-0.87-0.76%
BAXBaxter International...-0.37-0.58%
VRTXVertex Pharmaceutica...-0.16-0.10%
Data as of 4:00pm ET, 10/19/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.62
Annual revenue (last year)$4.9B
Annual profit (last year)$821.0M
Net profit margin16.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
New Jersey, New Jersey

Forecasts